3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Thrombocytosis
1
Neoplasms
1
Myeloproliferative Disorders
1
Leukemia
1
Interventions
Cyclophosphamide
9
ruxolitinib
7
Azacitidine
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Peripheral Blood Stem Cell Transplantation
6
Mycophenolic Acid
6
navitoclax
5
fludarabine
5
Therapeutics
5
Busulfan
5
ponatinib
4
Melphalan
4
Tacrolimus
3
Stem Cell Transplantation
3
Patient Reported Outcome Measures
3
Mesna
3
Immunoenzyme Techniques
3
Flow Cytometry
3
Cyclosporine
3
Clofarabine
3
Antilymphocyte Serum
3
vosaroxin
2
trametinib
2
liposomal amphotericin B
2
dabrafenib
2
Watchful Waiting
2
Transplantation
2
Sirolimus
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Base Sequence
×
Myeloid
×
Clear all
NCT06246006
2024-02-07
MPL - NPM
Centre Hospitalier Universitaire de NÄ«mes
Unknown
30 enrolled